2018-07146. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB Control No.Date approval expires
    Good Laboratory Practice Regulations for Nonclinical Studies0910-01191/31/2021
    Orphan Drug Designation Request Form and The Common European Medicines Agency/Food and Drug Administration Form for Orphan Medicinal Product Designation0910-01671/31/2021
    Electronic Records: Electronic Signatures0910-03031/31/2021
    Experimental Study on Warning Statements for Cigarette Graphic Health Warnings0910-08481/31/2021
    Start Printed Page 15153
    Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion0910-08491/31/2021
    Data to Support Drug Product Communications0910-06952/28/2021
    Applications for FDA Approval to Market a New Drug0910-00013/31/2021
    Animal Drug Adverse Event Reporting and Recordkeeping0910-02843/31/2021
    Extralabel Drug Use in Animals0910-03253/31/2021
    Application for Participation in FDA Fellowship Programs0910-07803/31/2021
    Start Signature

    Dated: April 3, 2018.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2018-07146 Filed 4-6-18; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
04/09/2018
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2018-07146
Pages:
15152-15153 (2 pages)
Docket Numbers:
Docket Nos. FDA-2014-N-0075, FDA-2011-N-0015, FDA-2011-N-0076, FDA-2017-N-0932, FDA-2016-N-4487, FDA-2014-N-0345, FDA-2013-N-0523, FDA-2017-N-2428, FDA-2008-N-0312, and FDA-2014-N-1072
PDF File:
2018-07146.pdf